The START Center for Cancer Research (“START”), a global leader in early-phase oncology clinical trials, announces the expansion of its network with the acquisition of Carolina Urologic Research Center (“CURC”) the premier urologic clinical research site specializing in genitourinary (GU) oncology. This acquisition strengthens START’s capabilities in one of oncology’s fastest-growing disease areas. Founded in 1998 by Neal Shore, MD, FACS, CURC has conducted nearly 500 clinical trials, making it the top urologic oncology site worldwide by both volume and quality. With deep expertise in early phase as well as late phase trials, CURC brings unparalleled leadership and scientific insight to START’s global research portfolio.
Read the full article: START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center //
Source: https://www.prnewswire.com/news-releases/start-further-expands-its-global-oncology-site-network-with-the-addition-of-carolina-urologic-research-center-302403985.html